PB

Philipp Bräuer

Vice President at EQT Life Sciences, Venture Capital

Munich, Bavaria

Invests in

Stages:

Locations:

  • Min Investment:

    $11,000,000.00
  • Max Investment:

    $65,000,000.00
  • Target Investment:

    $25,000,000.00

Education

Work Experience

  • Vice President

    2024

  • Associate

    2022 - 2024

Innovative Molecules GmbH

2022

  • Board Observer

    2022

2021 - 2022

  • Analyst

    2021 - 2022

    Analyst at EQT Life Sciences (formerly LSP), part of the investment team focused on private companies and involved in all stages of the investment process, especially deal flow screening and scientific due diligence.

2020 - 2021

  • Analyst

    2020 - 2021

    Fellow at M Ventures, the strategic corporate VC of Merck. Supporting the team in all aspects of the fund pipeline including scouting, deal flow, due diligence, portfolio company support and exits.

  • Year in Research

    2013 - 2014

    Research in structural biology group, conducting research on intraflagellar trans- port proteins. Performed a full crystallographic research project from inception to publication, working together with a variety of team members to accomplish this in only nine months.

  • Intern

    2012 - 2012

    Summer internship focused on BBSome proteins in intraflagellar transport. Performed molecular cloning, expression and purification. Worked as an independent member of a small team.

  • Intern

    2009 - 2009

    Two week internship in a small biotech company focused on small molecule drug development and target discovery, involving mass spectrometry, mammalian tissue culture and analysis of mouse organ protein composition.